Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: WeissLaw LLP Reminds IPHI, OBLN, IACA, and TPGY Shareholders About Its Ongoing Investigations

TBLAW

PR Newswire

NEW YORK , March 1, 2021 /PRNewswire/ --

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16 th Floor
New York , NY 10036
(212) 682-3025
(888) 593-4771

stockinfo@weisslawllp.com

Inphi Corporation (NASDAQ: IPHI)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Inphi Corporation (NASDAQ: IPHI) in connection with the company's proposed merger with Marvell Technology Group Ltd. Under the terms of the agreement, IPHI shareholders will receive $66.00 in cash and 2.323 shares of the newly-combined company for each IPHI share that they own. If you own IPHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/iphi/

Obalon Therapeutics, Inc. (NASDAQ: OBLN)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (NASDAQ: OBLN) in connection with the proposed merger of the company with ReShape Lifesciences Inc. ("ReShape"). Under the terms of the merger agreement, ReShape will acquire OBLN in an all-stock transaction, pursuant to which OBLN will be renamed ReShape Lifesciences Inc. If you own OBLN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/obln/

ION Acquisition Corp. 1 Ltd. (NYSE: IACA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ION Acquisition Corp. 1 Ltd. (NYSE: IACA) in connection with the company's proposed merger with Taboola.com Ltd. ("Taboola"). Under the terms of the merger agreement, IACA will acquire Taboola through a reverse merger that will result in Taboola becoming a public company traded on the NYSE. If you own IACA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/iaca/

TPG Pace Beneficial Finance Corp. (NYSE: TPGY)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TPG Pace Beneficial Finance Corp. (NYSE: TPGY) in connection with the company's proposed merger with EV Charged B.V. ("EVBox"). Under the terms of the merger agreement, TPGY will acquire EVBox through a reverse merger, with EVBox surviving as the new publicly-traded company. If you own TPGY shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/tpgy/

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-iphi-obln-iaca-and-tpgy-shareholders-about-its-ongoing-investigations-301237809.html

SOURCE WeissLaw LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today